These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11972292)

  • 1. Cessation of pulmonary and coronary secretion of adrenomedullin peptides in the progression of human heart failure.
    Stangl K; Dschietzig T; Richter C; Stangl V; Bartsch C; Zurbrügg HR; Pregla R; Baumann G; Felix SB; Laule M
    Horm Metab Res; 2002 Feb; 34(2):81-6. PubMed ID: 11972292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure.
    Øie E; Ahmed MS; Ueland T; Sikkeland LI; Dahl CP; Hagelin EM; von Lueder T; Edvardsen T; Andreassen AK; Gullestad L; Aukrust P; Yndestad A; Vinge LE; Attramadal H
    Basic Res Cardiol; 2010 Jan; 105(1):89-98. PubMed ID: 19823891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide concentrations in patients with heart failure.
    Gao YQ; Li ZL; Wu HC; Tang CS; Zhong P; Lu Q; Yan QN
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):632-4. PubMed ID: 12376296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
    Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
    J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of prepro-adrenomedullin with a putative adrenomedullin receptor gene in vascular smooth muscle.
    Autelitano DJ; Tang F
    Clin Sci (Lond); 1999 May; 96(5):493-8. PubMed ID: 10209081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure.
    Totsune K; Takahashi K; Mackenzie HS; Murakami O; Arihara Z; Sone M; Mouri T; Brenner BM; Ito S
    Clin Sci (Lond); 2000 Dec; 99(6):541-6. PubMed ID: 11099398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: possible role of adrenomedullin in pulmonary hypertension.
    Nishikimi T; Nagata S; Sasaki T; Yoshihara F; Nagaya N; Horio T; Matsuo H; Matsuoka H; Kangawa K
    Clin Sci (Lond); 2001 Jan; 100(1):61-6. PubMed ID: 11115419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.
    Stangl K; Dschietzig T; Richter C; Laule M; Stangl V; Tanis E; Baumann G; Felix SB
    Circulation; 2000 Sep; 102(10):1132-8. PubMed ID: 10973842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status.
    Silaghi A; Achard V; Paulmyer-Lacroix O; Scridon T; Tassistro V; Duncea I; Clément K; Dutour A; Grino M
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1443-50. PubMed ID: 17878224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adrenomedullin receptor acts as clearance receptor in pulmonary circulation.
    Dschietzig T; Azad HA; Asswad L; Böhme C; Bartsch C; Baumann G; Stangl K
    Biochem Biophys Res Commun; 2002 Jun; 294(2):315-8. PubMed ID: 12051712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.
    Schwarz N; Renshaw D; Kapas S; Hinson JP
    J Endocrinol; 2006 Aug; 190(2):505-14. PubMed ID: 16899583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S; Adamopoulos S; Parissis JT; Rassias J; Kostakis G; Iliodromitis E; Degiannis D; Kremastinos DT
    Int J Cardiol; 2005 Mar; 99(3):409-13. PubMed ID: 15771921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure.
    Hirose T; Totsune K; Mori N; Morimoto R; Hashimoto M; Nakashige Y; Metoki H; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Sasano H; Kohzuki M; Takahashi K; Imai Y
    Eur J Heart Fail; 2008 Sep; 10(9):840-9. PubMed ID: 18692436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
    Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
    Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension induced by nitric oxide synthase inhibitor increases responsiveness of ventricular myocardium and aorta of rat tissue to adrenomedullin stimulation in vitro.
    Pan CS; Jiang W; Zhong GZ; Zhao J; Pang YZ; Tang CS; Qi YF
    Life Sci; 2005 Dec; 78(4):398-405. PubMed ID: 16212982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease.
    Nishikimi T; Shibasaki I; Iida H; Asakawa H; Matsushita Y; Mori H; Mochizuki Y; Okamura Y; Horinaka S; Kangawa K; Shimada K; Matsuoka H
    Clin Sci (Lond); 2002 Jun; 102(6):669-77. PubMed ID: 12049623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.
    Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K
    Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.